Tyra Biosciences, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$0.41 | -$0.41 | -$0.41 |
Q2 2024 | 2 | -$0.40 | -$0.40 | -$0.40 |
Q3 2024 | 6 | -$0.56 | -$0.41 | -$0.49 |
Q1 2025 | 2 | -$0.54 | -$0.44 | -$0.49 |
Q2 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
Q3 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
Q4 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
Q1 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
Q2 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
Q3 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
Q4 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
Tyra Biosciences, Inc. Earnings Date And Information
Tyra Biosciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.4 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tyra Biosciences, Inc. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -11.16. Tyra Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based on prior year's report dates.
Tyra Biosciences, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.40 | -$0.41 | -0.01 | $0 | $0 |
08/07/2024 | Q2 2024 | -$0.41 | -$0.32 | 0.09 | $0 | $0 |
05/09/2024 | Q1 2024 | -$0.46 | -$0.35 | 0.11 | $0 | |
03/19/2024 | Q4 2023 | -$0.48 | -$0.53 | -0.05 | $502,000 | |
11/07/2023 | Q3 2023 | -$0.35 | -$0.49 | -0.14 | $0 | |
08/10/2023 | Q2 2023 | -$0.34 | -$0.31 | 0.03 | $0 | |
05/04/2023 | Q1 2023 | -$0.37 | -$0.22 | 0.15 | $0 | |
03/22/2023 | Q4 2022 | -$0.35 | $0.46 | 0.81 | $0 | |
11/03/2022 | Q3 2022 | -$0.41 | -$0.27 | 0.14 | $0 | |
08/04/2022 | Q2 2022 | -$0.33 | -$0.35 | -0.02 | $0 | |
05/05/2022 | Q1 2022 | -$0.20 | -$0.36 | -0.16 | $0 | |
03/03/2022 | Q4 2021 | -$0.21 | -$0.24 | -0.03 | $0 | |
11/03/2021 | Q3 2021 | -$0.29 | -$0.72 | -0.43 | $0 | |
06/30/2021 | Q2 2021 | -$0.15 | $0 | |||
03/31/2021 | Q1 2021 | -$0.19 | $0 | |||
12/30/2020 | Q4 2020 | -$0.16 | $0 | |||
09/29/2020 | Q3 2020 | -$0.10 | $0 | |||
06/29/2020 | Q2 2020 | -$1.27 | $0 | |||
03/30/2020 | Q1 2020 | -$1.07 | $0 |
Tyra Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Tyra Biosciences, Inc.'s earnings date?
Tyra Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based off last year's report dates.
-
How can I listen to Tyra Biosciences, Inc.'s earnings conference call?
The conference call for Tyra Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Tyra Biosciences, Inc.'s conference call transcript?
The conference call transcript for Tyra Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Tyra Biosciences, Inc. generate each year?
Tyra Biosciences, Inc. (:TYRA) has a recorded net income of $0. Tyra Biosciences, Inc. has generated $-1.62 earnings per share over the last four quarters.
-
What is Tyra Biosciences, Inc.'s price-to-earnings ratio?
Tyra Biosciences, Inc. (:TYRA) has a price-to-earnings ratio of -11.16 and price/earnings-to-growth ratio is -0.38.